Patient selection and reproducibility are essential in carotid revascularisation—regardless of chosen modality

48

Following a lively, three-pronged debate on the ‘gold standard’ in carotid revascularisation at this year’s Charing Cross (CX) Symposium (23–25 April, London, UK), a trio of vascular experts sat down in the CX Studio to discuss their favoured procedural modalities for treating carotid artery stenosis.

In this extended roundtable session, carotid artery stenting (CAS), carotid endarterectomy (CEA) and transcarotid artery revascularisation (TCAR) are represented by Christopher Metzger (OhioHealth, Columbus, USA), Domenico Valenti (King’s College London, London, UK), and Michael Stoner (University of Rochester, Rochester, USA), respectively.

The panellists highlight considerations over symptomatic versus asymptomatic carotid stenosis patients, outline their preferred imaging and anaesthesia protocols in carotid revascularisation cases, and discuss how CAS, CEA and TCAR—in terms of both procedural technique and clinical evidence—have all evolved over time. 


LEAVE A REPLY

Please enter your comment!
Please enter your name here